Researchers discuss efforts to improve PrEP access in transgender and other transmasculine men who are under-represented in research and prevention efforts.
A novel point-of-care urine test for PrEP drug levels predicted PrEP discontinuation in young people more accurately than self-reported PrEP adherence.
Point-of-care urine tenofovir rapid assay testing predicted pre-exposure prophylaxis (PrEP) discontinuation among young men who have sex with men and transgender women more accurately than self-reported adherence.